Jimmy Dore – Pfizer forecasts $32bn in revenue for COVID-19 vaccine Comirnaty, and $22bn for oral COVID-19 treatment Paxlovid, in 2022 pic.twitter.com/XW56L8gKFy
— Wittgenstein (@backtolife_2023) August 3, 2022
h/t CFP
Jimmy Dore – Pfizer forecasts $32bn in revenue for COVID-19 vaccine Comirnaty, and $22bn for oral COVID-19 treatment Paxlovid, in 2022 pic.twitter.com/XW56L8gKFy
— Wittgenstein (@backtolife_2023) August 3, 2022
h/t CFP